Request for Proposals: Preclinical Drug Combinations Study
The TB Alliance is sponsoring a systematic, preclinical study looking into various drug combinations for the treatment of tuberculosis. The
The TB Alliance is sponsoring a systematic, preclinical study looking into various drug combinations for the treatment of tuberculosis. The
TB Alliance Applauds Actions by Health Leaders on XDR-TB and Says More Resources are Needed to Speed Development of New
On a visit this week to Peru, Dr. Maria C. Freire, CEO and President of the TB Alliance, was honored
As part of its “underreported” news series, public radio’s Leonard Lopate Show today explored TB’s impact on the HIV/AIDS epidemic,
LISBON — Tuberculosis experts now generally agree that the number-one priority for improving TB therapy is to shorten and simplify
A new study has concluded that a shorter tuberculosis treatment regimen could save millions of lives over the next three
Treatment Action Group, a TB Alliance stakeholder organization, today released preliminary results from its survey of major funders of TB
At their 2006 annual meeting, held July 15-17 in St. Petersburg, Russia, the Group of 8 industrialized nations (Canada, France,
Die Stiftung von Microsoft-Gründer Bill Gates will weltweit Seuchen bekämpfen – und agiert dabei wie ein Pharmakonzern Martin Springsklee redet
On June 30, Dr. Maria C. Freire, President and CEO of the TB Alliance, met with Indian Minister of Health